City

Calgary (1)

Edmonton (1)

New York (1)

Condition

Leukemia, Erythroblastic, Acute (2)

Leukemia, Megakaryoblastic, Acute (1)

Leukemia, Monocytic, Acute (1)

Leukemia, Myeloid, Acute (1)

Leukemia, Myelomonocytic, Acute (1)

Myelodysplastic Syndromes (1)

Overall Status

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

University of Alberta (1)

Weill Medical College of Cornell University (1)

Collaborator

Intervention

5-azacytidine (1)

alemtuzumab (1)

cytarabine (1)

fludarabine (1)

idarubicin (1)

melphalan (1)

total body irradiation (1)

volasertib (1)

Study Documents

Intervention Type

drug (2)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

leukemia, erythroblastic, acute

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Leukemia, Erythroblastic, Acute, MDS Trial in New York (5-Azacytidine, Fludarabine, Melphalan)

Completed

Has Results

Leukemia, Erythroblastic, Acute
Myelodysplastic Syndromes

5-Azacytidine
+4 more

New York, New York

Weill Cornell Medical College

Aug 25, 2021

Leukemia, Myeloid, Acute, Leukemia, Monocytic, Acute, Leukemia, Myelomonocytic, Acute Trial in Calgary, Edmonton (Volasertib,

Withdrawn

Leukemia, Myeloid, Acute
+4 more

Volasertib
+2 more

Calgary, Alberta, Canada
+1 more

Apr 3, 2017